Tandem Diabetes Care, Inc. (TNDM)

NASDAQ: TNDM · IEX Real-Time Price · USD
53.57
-1.68 (-3.04%)
Aug 16, 2022 11:10 AM EDT - Market open
-3.04%
Market Cap 3.44B
Revenue (ttm) 765.79M
Net Income (ttm) -13.17M
Shares Out 64.22M
EPS (ttm) 0.08
PE Ratio 669.63
Forward PE 454.55
Dividend n/a
Ex-Dividend Date n/a
Volume 238,141
Open 54.96
Previous Close 55.25
Day's Range 53.05 - 55.03
52-Week Range 52.08 - 155.86
Beta 0.78
Analysts Buy
Price Target 133.70 (+149.6%)
Earnings Date Aug 3, 2022

About TNDM

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update the... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Nov 14, 2013
CEO John Sheridan
Employees 2,000
Stock Exchange NASDAQ
Ticker Symbol TNDM
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 19 analysts, the average rating for TNDM stock is "Buy." The 12-month stock price forecast is 133.7, which is an increase of 149.58% from the latest price.

Price Target
$133.7
(149.58% upside)
Analyst Consensus: Buy
Stock Forecasts

News

5 Toxic Stocks That May Prove Hazardous for Your Portfolio

Toxic companies are characterized by huge debt pile and are vulnerable to external shocks. Accurately identifying such stocks and getting rid of them at the right time can protect your portfolio.

Other symbols: CSHSKALVS

Why Tandem Diabetes Care Stock Is Cratering Today

The diabetes specialist's Q2 financial report isn't sitting well with investors.

Tandem Diabetes (TNDM) Q2 Earnings Miss, Sales View Cut

Factoring the pandemic and competitive pressure as well as the evolving economic environment, including inflation and the threat of recession, Tandem Diabetes (TNDM) cuts its full-year guidance.

Tandem Diabetes Care Announces Second Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #ControlIQ--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarte...

Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced its acquisition of infusion set developer, Capi...

Tandem Diabetes Care to Announce Second Quarter 2022 Financial Results on August 3, 2022

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2022 results after the fi...

Tandem Diabetes (TNDM) New Launches Aid Growth Amid Cost Woes

Tandem Diabetes (TNDM) witnesses strong customer retention, driven by the impressive positive response from the Control-IQ technology.

Tandem Diabetes (TNDM) Global Pump Sales Aid, Price Issue Ails

Tandem Diabetes (TNDM) is witnessing strong customer retention, driven by the impressive positive response from the Control-IQ technology.

Here's Why Investors Should Retain Tandem Diabetes (TNDM) Now

Investors are optimistic about Tandem Diabetes' (TNDM) strong pump shipments and ongoing product innovations.

Tandem Diabetes Care, Inc. (TNDM) Soars 6%: Is Further Upside Left in the Stock?

Tandem Diabetes Care, Inc. (TNDM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further stre...

Tandem Diabetes Care Welcomes Two New Members to Board of Directors

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today announced the appointments of Myoung Cha and Joao Malagu...

2 Beaten-Down Stocks With 80% to 113% Upside, According to Wall Street

These diabetes specialists are down but not out.

Other symbols: DXCM

Tandem Diabetes (TNDM) Posts Positive Control-IQ Study Data

Data presented at the ADA conference demonstrates Tandem Diabetes' (TNDM) Control-IQ technology's ability to make a positive and sustained impact across a diverse group of people with diabetes.

Control-IQ Technology Continues to Demonstrate Positive and Sustained Real-World Benefits Across Diverse Cohorts of P...

NEW ORLEANS--(BUSINESS WIRE)---- $TNDM #TNDM--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced positive real-world data demonstrating immedi...

Why Is Tandem Diabetes Care, Inc. (TNDM) Down 16.3% Since Last Earnings Report?

Tandem Diabetes Care, Inc. (TNDM) reported earnings 30 days ago. What's next for the stock?

The 10 Best High-Growth Stocks to Buy

Except for energy stocks, 2022 has been a very difficult year to find any equities able to perform well in these volatile markets. And high-growth stocks have been hit especially hard.

Tandem Diabetes (TNDM) Pump Shipment Recovers, Price Issue Ails

Tandem Diabetes (TNDM) witnesses strong customer retention, driven by the impressive positive response from the Control-IQ technology.

Tandem Diabetes Care Announces Upcoming Virtual Conference Presentation

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today announced that management will present a company u...

Tandem Diabetes (TNDM) Q1 Earnings Lag Estimates, Sales View Up

Robust pump shipments and growth in the installed customer base are driving Tandem Diabetes' (TNDM) first-quarter top line.

Tandem Diabetes Care Announces First Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #ControlIQ--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading global insulin delivery and diabetes technology company, today reported its financial results for th...

Real-World Evidence Confirms Immediate and Ongoing Performance of the t:slim X2 Insulin Pump with Control-IQ Technolo...

BARCELONA, Spain--(BUSINESS WIRE)---- $TNDM #ATTD2022--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced real-world data confirming that use ...

Tandem Diabetes Care to Announce First Quarter 2022 Financial Results on May 4, 2022

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2022 results after the fin...

Why Is Tandem Diabetes Care, Inc. (TNDM) Up 4.5% Since Last Earnings Report?

Tandem Diabetes Care, Inc. (TNDM) reported earnings 30 days ago. What's next for the stock?

Tandem Diabetes (TNDM) Q4 Earnings Lag Estimates, Revenues Top

Robust domestic and international pump shipments are driving Tandem Diabetes' (TNDM) fourth-quarter top line.

Tandem Diabetes Care, Inc. (TNDM) Q4 Earnings Lag Estimates

Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of -20% and 6.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?